Ultrasound versus Cone-beam CT image-guided radiotherapy for prostate and post-prostatectomy pretreatment localization.
Phys Med 2015;
31:997-1004. [PMID:
26422200 DOI:
10.1016/j.ejmp.2015.07.147]
[Citation(s) in RCA: 16] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/18/2015] [Revised: 07/15/2015] [Accepted: 07/28/2015] [Indexed: 11/22/2022] Open
Abstract
PURPOSE
To evaluate the accuracy of an intra-modality trans-abdominal ultrasound (TA-US) device against soft-tissue based Cone-Beam Computed tomography (CBCT) registration for prostate and post-prostatectomy pre-treatment positioning.
METHODS
The differences between CBCT and US shifts were calculated on 25 prostate cancer patients (cohort A) and 11 post-prostatectomy patients (cohort B), resulting in 284 and 106 paired shifts for cohorts A and B, respectively. As a second step, a corrective method was applied to the US registration results to decrease the systematic shifts observed between TA-US and CBCT results. This method consisted of subtracting the mean difference obtained between US and CBCT registration results during the first 3 sessions from the US registration results of the subsequent sessions. Inter-operator registration variability (IOV) was also investigated for both modalities.
RESULTS
After initial review, about 20% of the US images were excluded because of insufficient quality. The average differences between US and CBCT were: 2.8 ± 4.1 mm, -0.9 ± 4.2 mm, 0.4 ± 3.4 mm for cohort A and 1.3 ± 5.0 mm, -2.3 ± 4.6 mm, 0.5 ± 2.9 mm for cohort B, in the anterior-posterior (AP), superior-inferior (SI) and lateral (LR) directions, respectively. After applying the corrective method, only the differences in the AP direction remained significant (p < 0.05). The IOV values were between 0.6-2.0 mm and 2.1-3.5 mm for the CBCT and TA-US modalities, respectively.
CONCLUSIONS
Based on the obtained results and on the image quality, the TA-US imaging modality is not safely interchangeable with CBCT for pre-treatment repositioning. Treatment margins adaptation based on the correction of the systematic shifts should be considered.
Collapse